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Innovative pharmacological approaches to control the excessive neutrophil inﬁltrates
into the bronchial lumen of CF patients are thought to be beneﬁcial to reduce the
extensive airway tissue damage. The activation of expression of pro-inﬂammatory
genes by P. aeruginosa with bronchial epithelial cells is a central mechanism to
be targeted with novel therapies. Medicinal plants are attracting a growing interest
because of their potential safety, already tested in large scale applications in human
diseases. However, due to the presence of different active principles in each plant
extract, whose multifunctional effects may even result contradictory, understanding
the effect of each component is mandatory to pursue selective and reproducible
applications. A panel of medicinal plant extracts have been ﬁrstly screened for
their capacity to interfere in the binding of nuclear transcription factor proteins (TF)
with DNA consensus sequences identiﬁed in the promoters of the pro-inﬂammatory
genes, thus for their potential inhibitory action on gene expression. Extracts from
Emblica ofﬁcinalis (EO), Aegle marmelos (AM), Polyalthia longifolia (PL) have
been screened for their ability to interfere with the TFs NF-úB, AP-1 and CREB
induced by P. aeruginosa and have been shown to inhibit TF/DNA interactions,
opening the possibility of potential applications to down-regulate expression of pro-
inﬂammatory genes. Extracts from EO, AM, PL were tested in IB3−1 bronchial cells
exposed to the P. aeruginosa PAO1. EO, AM and PL strongly inhibited the PAO1-
dependent transcription of IL-8 in IB3−1 cells. Pyrogallol, one active principle
of EO, was tested in IB3−1 cells, where it inhibited the transcription of IL-8,
GRO-a and g, of ICAM-1 and IL-6, similarly to the whole EO extract, whereas a
second active principle from EO, namely 5-hydroxy-isoquinoline, had no effect. In
conclusion, extracts from plants of the traditional medicine can inhibit expression
of pro-inﬂammatory genes and screening active principles puriﬁed from medicinal
plants could result useful to identify safe and innovative pharmaceutical molecules
to control lung inﬂammation in the lung of CF patients.
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The role of CFTR deﬁciency in promoting inﬂammation remains unclear. It has
been recently reported by Perez et al. that the inhibition of function of w/t CFTR
produces an inﬂammatory proﬁle that resembles that observed in CF patients [Am J
Physiol Lung Cell Mol Physiol, 2007], whereas we demonstrated that correction of
F508del CFTR function with MPB-07 down modulates the P. aeruginosa dependent
expression of the pro-inﬂammatory mediators IL-8 and ICAM-1 in CF bronchial
cells [Am. J. Resp. Cell. Mol Biology, 2007]. Since both evidence support a direct
link between CFTR function and inﬂammation, we extended our investigation to
other F508del CFTR correctors, such as miglustat [FEBS letters, 2006], which is
an approved drug for Gaucher disease, in comparison with an isomer without any
correcting effect, namely NB-DGJ. Miglustat signiﬁcantly reduced the expression
of IL-8 and ICAM-1 in CF bronchial cells IB3−1 and in CuFi-1, upon infection by
PAO1 or stimulation with TNFa or IL-1b and restored CFTR function. Miglustat
had no major effects on overall binding activity of transcription factors NF-kB and
AP-1, activated by PAO1 in these cell lines. NB-DGJ, which is not a corrector of
function of F508del CFTR, down modulated the inﬂammatory response in CF cells.
In addition, both miglustat and NB-DGJ produced the same anti-inﬂammatory effect
in non CF NuLi-1 cells. In conclusion, miglustat is a corrector of F508del CFTR
function in CF bronchial IB3−1 and CuFi-1 cells and has an anti-inﬂammatory
effect which is independent of the correction of F508del CFTR, by interfering with
the pro-inﬂammatory signaling downstream the receptors for pathogens and pro-
inﬂammatory cytokines. Since miglustat is already approved for the treatment of
Gaucher disease and other glycosphingolipidoses, it could represent an interesting
new molecule to ameliorate lung inﬂammation in CF patients.
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Massive inﬁltrates of neutrophils in the mucosal wall and lumen of the conductive
airways of CF patients contribute to the progressive lung function decline by releas-
ing different proteases responsible for the progressive airway tissue damage. Bacte-
rial products and pathogens themselves within the mucopurulent material of the air-
way surface ﬂuid induce the activation of transcription factors such as NF-kappaB,
AP-1, Sp1, NF-IL6, NF-AT, Elk-1, CREB resulting in expression of chemo/cytokine
genes driving the recruitment of leukocytes inside the bronchial lumen. We are
exploring the transcription factor (TF) “decoy” strategy, in which oligodeoxynu-
cleotides (ODN) mimicking the consensus sequences for the TFs proteins identiﬁed
in the promoters of different chemo/cytokines are delivered inside the cell in order
to interfere with gene transcription. CF bronchial epithelial cells IB3−1 have been
exposed to the P. aeruginosa strain PAO1. Transcription of genes involved in innate
immune response has been quantiﬁed by real-time (RT) PCR. Transcription factor
“decoy” ODNs directed against the consensus sequences identiﬁed in the promoters
of different genes have been designed and validated by testing their interference
in TF protein/DNA binding assays. Transfection of IB3−1 cells with HIV-1 LTR
and IgK chain NF-kB ODN “decoys” complexed with Lipofectamine, performed
30 hrs before challenge with PAO1, was shown previously to inhibit strongly PAO1-
dependent transcription of IL-8. Therefore other TF “decoy” ODNs have been also
tested: (a) ODN for NF-kB from IL-8 promoter inhibited IL-8, GRO-gamma and
IL-6; (b) ODN for Sp1 from HIV-1 genome inhibited IL-6; (c) ODN for AP-1 from
IL-8 promoter inhibited both IL-8 and GRO-gamma. In conclusion, transcription
of cytokines in CF bronchial epithelial cells in vitro can be inhibited with different
efﬁciency and selectivity by TF “decoy” molecules. These results provide useful
hints for a gene-targeted anti-inﬂammatory approach and add further information on
the regulation of expression of pro-inﬂammatory genes in bronchial epithelial cells.
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We have demonstrated an important role for NHERF1 in regulating CFTR localiza-
tion and stability on the apical membrane of normal cell monolayers [1]. NHERF1
over-expression in CFBE41o− (CFBE) cells induces a signiﬁcant increase both of
CFTR expression at the apical membrane and of the PKA-dependent activation of
chloride efﬂux. We hypothesize that this rescue of DF508CFTR-dependent chloride
secretion induced by NHERF1 over-expression could be driven by the interaction of
the actin cytoskeleton with the ezrin-NHERF1-CFTR multiprotein complex. Indeed,
confocal analysis demonstrated that normal 16HBE14o− (HBE) cells have a well-
organized actin cytoskeleton, while CFBE cells have a substantial disassembly of
actin ﬁlaments. Importantly, over-expression of NHERF1 in the CFBE cells led to
an F-actin cytoskeleton reorganization into well organized stress ﬁbers on the apical
side that closely resemble the normal cells. These results suggest that an organized
cytoskeleton is critical for apical membrane CFTR expression and/or CFTR activity
and that NHERF1 has an essential role in regulating these mechanisms, possibly
through its interaction with cytoskeleton proteins such as ezrin. As only active ezrin
is able to bind to NHERF1, we analyzed the distribution of active P-T567-ezrin with
respect to total ezrin. Confocal analysis demonstrated that active ezrin colocalized
with NHERF1 at the apical membrane in HBE monolayers and in CFBE monolayers
over-expressing NHERF1 while it was mislocalized at basolateral membrane in
CFBE cell monolayers. These results were conﬁrmed by differential detergent
extraction experiments where the ratio active ezrin/total ezrin was increased in
CFBE cells transfected with NHERF1 with respect to CFBE cells. To investigate
how the association of CFTR with the multiprotein complex NHERF1-ezrin-actin
is regulated we focused our attention on the small GTPase RhoA, as RhoA has
been shown to activate ezrin. Constitutive active RhoA induced a rescue of CFTR
activity in CFBE cells while having no effect in either HBE cells or in CFBE
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cells over-expressing NHERF1. These data suggest that NHERF1 participates in
the organization of the actin cytoskeleton through activation of RhoA and ezrin.
Reference(s)
[1] Guerra et al., 2005, JBC 280:40925−33.
P44 SLEEP-DISORDERED BREATHING IN ADULTS AND CHILDREN
WITH CYSTIC FIBROSIS
L. Spicuzza, C. Sciuto, G. Di Dio, L. Bivona, M. Celi, M. La Rosa.
Broncopneumologia Pediatrica, Dipartimento di Pediatria, Universita` di
Catania, Catania, Italy
Chronic airway obstruction may determine early hypoxaemia during exercise and
sleep even in patients with normal diurnal blood gases. The aim of our study
was to establish the occurrence of sleep-disordered breathing (SDB) in a cohort
of patients with cystic ﬁbrosis (CF), followed in our Cystic Fibrosis Unit. We
therefore studied 55 patients (49% M; 36% children (mean age 4.3±3.9, SaO2
% awake 97.7±1.5); 64% adults (mean age 20.9±4.9, BMI 21.1±3.6, SaO2 %
awake 97.1±1.1). All patients, in stable clinical conditions, underwent a nocturnal
standard polysomnography (sleep monitoring system Compumedics S-Series) and
respiratory functional evaluation during the day. Scoring of respiratory events was
performed according to standard criteria. Polysomnographic monitoring revealed the
occurrence of SDB, deﬁned as an apnea-hypopnea index (AHI) >5, in 52% of adults
and in 56% of children. In adults we found mean AHI 16.8±7.8, mean nocturnal
SaO2 93.9%±2.3, mean SaO2 min 88.2%±2.2; in children we found mean AHI
12.5±5.8, mean nocturnal SaO2 93.7%±1.2, mean SaO2 min 89.2%±3.2. In both
adults and children we found a similar prevalence of upper airways obstruction
(sinusitis and rhinitis), a major cause of SDB, in groups with SDB and without
SDB. In adults we found a lower mean FEV1% in the group with SDB as compared
to the group without SDB (50% vs 64%, respectively).
These data show a high prevalence of sleep-disordered breathing in patients with
cystic ﬁbrosis. In these patients SDB occurs in an early phase of life and in
adulthood SDB seems to be associated to a lower respiratory function.
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Background: Shorter patients are much more likely to die before taller patients.
Based on these data, short stature should not be considered benign to patients with
cystic ﬁbrosis. Several studies have also well established that children with normal
lung function have a signiﬁcantly better nutritional status. Stature is an easy criteria
to screen patients at risk of malnutrition. Inﬂuence of nutritional status on lung
function (FEV1) has never been assessed in Italy.
Aim: To evaluate the correlation between stature, age and FEV1 in Italian CF
patients.
Patients and Methods: We enrolled 620 CF patients aged 6−18 years (F 51%,
mean age 11±5.3 yrs) followed-up in 10 Italian Reference Centres. Patients were
divided into 3 age-groups (6−9, 10−14 and 15−18 yrs). We compared these groups
by calculation of Height-for-age Z-score (HAZ) and lung function expressed as
FEV1% predicted.
Results: Trend of relationship between FEV1 and HAZ is shown in ﬁgure 1.
Fig. 1. HAZ and FEV1 progressively decrease with age (6−9 yrs: HAZ −0.23,
FEV1 93.4%; 15−18 yrs: HAZ −0.93, FEV1 78.3%).
Conclusions: Also in Italian CF patients HAZ decreases with age, as well as FEV1.
Early identiﬁcation and treatment of malnutrition is essential to start an adequate
supporting feeding and to prevent a long-term worse outcome, in terms of quality
of life, lung status and, ultimately, survival.
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Background: Cystic Fibrosis (CF) is a chronic disease characterized by an in-
creased energy demand. Nutritional management is difﬁcult for several clinical and
psychosocial reasons but an early detection of malnutrition is essential for a better
prognosis. Different auxologic indexes have been used to identify malnutrition but,
presently, a gold-standard is not yet available.
Aims: To compare (a) growth charts of Italian CF patients and normal subjects,
and (b) different auxologic indexes in evaluating malnutrition as a function of age.
Patients and Methods: We studied 941 CF patients aged 0−18 years (M 51.1%,
mean age 9.2±6.4 yrs) followed-up in 10 Italian Reference Centres. Height-for-Age
percentile (HAP), Weight-for-Age percentile (WAP) and BMI were calculated in
all patients and used to draw the correspondent growth charts in two sexes. We
compared the course of 50th percentile (pc) in CF patients and normal subjects
(CDC 2000). We also calculated Weight-for-Length pc (WLP) in patients < 2 years
and BMI pc (BMIp) in patients aged 2−18 years. We compared the course of HAP,
WLP and BMIp in patients with real malnutrition, alone (HAP< 5th, WLP< 10th
and BMIp< 10th) and together with those at risk for malnutrition (HAP, WLP and
BMIp< 25th).
Results: HAP, WAP and BMI 50th pcs in CF patients were lower than normal sub-
jects, in both sexes and at all ages considered. HAP and WLP had a similar course
(HAP< 5th: 14% and WLP< 10th: 12.9%; HAP< 25th: 35.1% and WLP< 25th:
35.7%). BMIp< 10th seemed a better index than HAP< 5th, mainly in the pre-
pubertal age (2−5 yrs: 14.3 vs 7.1%; 14−18 yrs: 23 vs 21.9%, respectively). On the
other hand, the frequency of BMIp< 25th was higher than HAP< 25th only in the
ﬁrst years of life (2−5 yrs: 42.2 vs 33.7%, respectively); HAP< 25th progressively
became more frequent than BMIp< 25th (14−18 yrs: 55.8 vs 38.8%, respectively).
Conclusions: Our results show that Italian CF children have subnormal growth
at all ages. Not a single but a combination of different indexes may be useful to
correctly identify and better manage malnutrition.
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
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Background: About 10−30% of adult patients with acute recurrent episodes or
signs of chronic pancreatitis is deﬁned as suffering from Recurrent Idiopathic
Pancreatitis (RIP); on the other hand, the epidemiology of pancreatitis is not well
understood in pediatry. Furthermore, RIP can also be a manifestation of cystic
ﬁbrosis (CF). Several genetic studies have recently demonstrated a role of CFTR,
SPINK1 and PRSS1 genes in the pathogenesis of RIP.
Aim: to report the experience of a single centre in the evaluation of RIP occurrence
as the ﬁrst manifestation of CF.
Patients and Methods: We studied, retrospectively, 51 young patients (27 F, mean
age at diagnosis: 11.1±6.7 yrs) affected by recurrent acute pancreatitis and showing
signs of chronic pancreatitis. All patients were submitted to ERCP to exclude
bilio-pancreatic malformations. Patients without malformations underwent sweat
test and genetic analysis: CFTR gene was evaluated by DHPLC method and the
most common mutations of PRSS1 and SPINK1 genes were also studied.
Results: A bilio-pancreatic malformation was diagnosed in 12 patients (23.5%:
5 choledochus cyst, 2 pancreas divisum, 2 duodenal duplication, 2 choledochus
